Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Diagnosis and treatment tool for metastasis of gastric adenocarcinoma

A gastric adenocarcinoma, tool technology, applied in disease diagnosis, biochemical equipment and methods, instruments, etc., can solve problems such as unclear molecular mechanism

Active Publication Date: 2017-11-24
QINGDAO MEDINTELL BIOMEDICAL CO LTD
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, for advanced gastric cancer, the underlying molecular mechanism of invasion and metastasis is still unclear.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Diagnosis and treatment tool for metastasis of gastric adenocarcinoma
  • Diagnosis and treatment tool for metastasis of gastric adenocarcinoma
  • Diagnosis and treatment tool for metastasis of gastric adenocarcinoma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0065] Example 1 Differential expression of FBXO3 gene

[0066] 1. Sample collection

[0067] 50 cases of metastatic gastric adenocarcinoma tissues and their adjacent normal tissues were collected, and 45 cases of non-metastatic gastric adenocarcinoma tissues and their adjacent normal tissues were collected. The tissue samples were collected with the help of a pathologist, and the sample collection criteria were as follows: (1) primary gastric adenocarcinoma, no other diseases, and patients who had not undergone cancer radiotherapy and chemotherapy before surgery; (2) samples diagnosed as gastric adenocarcinoma by the pathology department, and the cancer (3) In order to avoid unnecessary cross-contamination, two sets of equipment were used for sampling. First, samples of normal tissue adjacent to cancer that were at least 5 cm away from the cancer tissue without obvious lesions were taken. For full-thickness gastric adenocarcinoma tissue samples, the samples were immediately ...

Embodiment 2

[0113] Example 2 Differential expression of FBXO3 protein

[0114] 1. Extract the total protein of the tissue sample in Example 1

[0115] Follow the instructions of the EpiQuik Tissue / Cell Total Protein Extraction Kit for protein extraction.

[0116] 2. Western blot

[0117] β-actin was used as internal reference. 50 μg of total protein was separated by SDS-PAGE, electrotransferred to PVDF membrane, and blocked with 1×TBST containing 5% skimmed milk powder at room temperature for 1 hour; adding rabbit anti-human FBXO3 monoclonal antibody (1:800 dilution) and mouse anti-human β-actin polyclonal antibody (diluted 1:3 000), overnight at 4°C; wash the membrane 4 times with 1×TBST, add goat anti-rabbit and goat anti-mouse IgG (diluted 1:2 000), incubate at room temperature for 1 h; 1×TBST After washing the membrane 4 times, put it in Super Signal chemiluminescent reagent to react for 2 minutes, expose the X-ray film in the dark room, develop and fix it by conventional method. ...

Embodiment 3

[0122] Example 3 FBXO3 gene overexpression

[0123] 1. Plasmid construction

[0124]Amplification primers are designed according to the coding sequence of the FBXO3 gene, and the design of primers is well known to those skilled in the art. Amplify the coding sequence of the full-length FBXO3 gene from the cDNA library of adult fetal brain (clontech company, article number: 638831), insert the above cDNA sequence into the eukaryotic cell expression vector pcDNA3.1, and connect the obtained recombinant vector pcDNA3.1 -FBXO3 was used for subsequent experiments.

[0125] 2. Culture of human gastric adenocarcinoma cells

[0126] Human gastric adenocarcinoma SGC7901 cells were treated with RPMI1640 medium containing 10% fetal bovine serum plus penicillin 100units / ml and streptomycin 100μg / ml, placed at 37°C, 5% CO 2 Cultured in an incubator, the culture medium was changed every 24 hours, and the cells were passaged once every 48 hours. Cells in the logarithmic growth phase were...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
cover factoraaaaaaaaaa
Login to View More

Abstract

The invention discloses an FBXO3 gene used as a molecular marker for diagnosing gastric adenocarcinoma. An experiment of the FBXO3 gene proves that compared with normal tissues, the expression quantity of the FBXO3 gene is low. The invention also discloses the FBXO3 gene which also can be used for preparing a medicine for treating the gastric adenocarcinoma. According to a research result of the FBXO3 gene disclosed by the invention, a new clinical diagnosis method of the gastric adenocarcinoma is provided, and meanwhile, a new drug target for treating the gastric adenocarcinoma is provided.

Description

technical field [0001] The invention relates to the field of tumor diagnosis and treatment, more specifically, the invention relates to a tumor diagnosis method by means of detecting FBXO3 abnormality; and a tumor therapeutic agent promoting FBXO3 gene or protein. Background technique [0002] Gastric cancer is a malignant tumor derived from gastric mucosal epithelial cells, mainly adenocarcinoma. In 2008, nearly 1 million cases of gastric cancer were newly diagnosed in the world, and the number of deaths was 740,000. It is the fourth most common cancer in the world and the second most lethal. Although the overall global incidence of gastric cancer has declined, nearly two-thirds of gastric cancer cases are concentrated in economically underdeveloped countries and regions, with high incidence in China and other East Asian countries. According to the latest version of "China Cancer Map" released by "Life Times" in 2014. There are about 3,120,000 new cancer cases in my count...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68G01N33/574A61K45/00A61P35/04
CPCA61K45/00C12Q1/6886C12Q2600/118C12Q2600/158G01N33/57446G01N2800/52G01N2800/54
Inventor 宋宏涛马翠
Owner QINGDAO MEDINTELL BIOMEDICAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products